Petros Pharmaceuticals, Inc.
Public company- Headquarters
- NEW YORK, New York
- Ticker
- PTPI
- CIK
- 0001815903
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Executive ChairmanJoshua N. Silverman | Sep 30, 2026 | Departed |
| DirectorBruce T. Bernstein | Sep 30, 2026 | Departed |
| President and Chief Commercial OfficerFady Boctor | Sep 30, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- PFIZER INC
CFO appointed: Cecile Guegan
- ROCKET PHARMACEUTICALS, INC.
WARN notice: Cranbury, NJ
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Executive departure
Executive Chairman departs: Joshua N. Silverman
Joshua N. Silverman, Executive Chairman of Petros Pharmaceuticals, Inc., resigns the role, effective September 30, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 30, 2026Role: Executive Chairman
- Executive departure
Director departs: Bruce T. Bernstein
Bruce T. Bernstein, Director of Petros Pharmaceuticals, Inc., resigns the role, effective September 30, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 30, 2026Role: Director
- Executive departure
Director departs: Wayne R. Walker
Wayne R. Walker, Director of Petros Pharmaceuticals, Inc., resigns the role, effective September 30, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 30, 2026Role: Director
- Executive departure
President and Chief Commercial Officer departs: Fady Boctor
Fady Boctor, President and Chief Commercial Officer of Petros Pharmaceuticals, Inc., leaves the role, effective September 30, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 30, 2026Role: President and Chief Commercial Officer
Last verified Nov 8, 2026